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Introduction
Systemic sclerosis (SSc) is a progressive disease, whose
pathogenesis includes early immunological events and
vascular alterations. There is a subgroup of patients
with a rapidly progressive disease or refractory to con-
ventional treatment which can benefit from intensive
immunosuppression and rescue with transplant of hae-
matopoietic progenitors (TPH).
Objectives
To report the first TPH for an autoimmune patient in
Portugal.
Methods
Restrospective review of the case file
Results
Clinical case: young female, 20 y.o., with SSc difuse
subtype, diagnosed at 13 y.o., with cutaneous, vascular
and articular involvement, with initial good response to
Methotrexate. Three years later there was progression of
the disease with severe gastrointestinal involvement
translated by disphagia and delayed gastric emptying non
responsive to treatment, including Cyclophosphamide
(Cyc) with subsequent important weight lost, and need of
nutritional support by gastrostomy.
In January of 2012 she was subjected to intermediate
dose immunosuppressive therapy with Cyc 4gr followed
by hematopoietic growth factors for mobilization and
collection of peripheral stem cells progenitors, and four
months latter autologous transplant was made with
myeloablative regimen (BEAM).
The patient suffered a grade 3 mucositis with need for
opyoid therapy and nutritional support with total par-
enteral nutrition during 5 days. She also had a herpes
zooster and a febrile syndrome without clinical focus
and without isolated agent. Hospital discharge day was
at day 17 post transplant.
In ambulatory regimen the patient became to have
had good oral food tolerance without need for nutritional
supplementation by gastrostomy and cutaneous and
vascular improvement.
Conclusion
This is the first TPH for an autoimmune patient in Portu-
gal, with a sequency therapy approach in consonance with
the european clinical guidelines protocols of the EBMT.
The authors emphasize the importance of an early identifi-
cation of patients with autoimmune diseases unresponsive
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